Veterinary Medicines

OVILIS PASTOVAX

Authorised
  • Mannheimia haemolytica, serotype A6, strain S1084/81, Inactivated
  • Mannheimia haemolytica, serotype A7, strain S1078/81, Inactivated
  • Bibersteinia trehalosi, serotype T4, strain S1085/81, Inactivated
  • Mannheimia haemolytica, serotype A2, strain S1126/92, Inactivated
  • Bibersteinia trehalosi, serotype T10, strain S1075/81, Inactivated
  • Mannheimia haemolytica, serotype A9, strain S994/77, Inactivated
  • Bibersteinia trehalosi, serotype T15, strain S1105/84, Inactivated
  • Mannheimia haemolytica, serotype A1, strain S1006/77, Inactivated
  • Bibersteinia trehalosi, serotype T3, strain S1109/84, Inactivated
Download as PDF

Product identification

Medicine name:
OVILIS PASTOVAX
Active substance:
  • Mannheimia haemolytica, serotype A6, strain S1084/81, Inactivated
  • Mannheimia haemolytica, serotype A7, strain S1078/81, Inactivated
  • Bibersteinia trehalosi, serotype T4, strain S1085/81, Inactivated
  • Mannheimia haemolytica, serotype A2, strain S1126/92, Inactivated
  • Bibersteinia trehalosi, serotype T10, strain S1075/81, Inactivated
  • Mannheimia haemolytica, serotype A9, strain S994/77, Inactivated
  • Bibersteinia trehalosi, serotype T15, strain S1105/84, Inactivated
  • Mannheimia haemolytica, serotype A1, strain S1006/77, Inactivated
  • Bibersteinia trehalosi, serotype T3, strain S1109/84, Inactivated
Target species:
  • Sheep
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Mannheimia haemolytica, serotype A6, strain S1084/81, Inactivated
  • Mannheimia haemolytica, serotype A7, strain S1078/81, Inactivated
  • Bibersteinia trehalosi, serotype T4, strain S1085/81, Inactivated
  • Mannheimia haemolytica, serotype A2, strain S1126/92, Inactivated
  • Bibersteinia trehalosi, serotype T10, strain S1075/81, Inactivated
  • Mannheimia haemolytica, serotype A9, strain S994/77, Inactivated
  • Bibersteinia trehalosi, serotype T15, strain S1105/84, Inactivated
  • Mannheimia haemolytica, serotype A1, strain S1006/77, Inactivated
  • Bibersteinia trehalosi, serotype T3, strain S1109/84, Inactivated
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Sheep
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI04AB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • ANSES
Authorisation number:
  • FR/V/5565060 1/2008
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."